Position in ARGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$773,760
+$321,005 QoQ
Shares Held
834
+34.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#272
of 507 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vise Technologies, Inc. holds $19,918,588 across 31 Biotechnology names. ARGX ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,882 | $3,915,225 | |
| 2 | RPRX |
Royalty Pharma plc
|
23,958 | $1,343,325 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,142 | $1,335,622 | |
| 4 | EXEL |
Exelixis, Inc.
|
15,708 | $854,672 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
9,366 | $814,373 | |
| 6 | INCY |
Incyte Corp
|
7,156 | $811,204 | |
| 7 | ARGX |
Argenx SE
This page
|
834 | $773,760 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
9,499 | $743,486 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $773,760 | 834 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $452,755 | 620 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $521,389 | 620 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $360,666 | 489 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $356,088 | 646 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $491,385 | 799 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $405,475 | 748 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||